Literature DB >> 33094434

High-Sensitive c-Reactive Protein Levels in Euthymic Bipolar Patients: Case-Control Study.

Ghada Hamdi1,2, Hanen Ben Ammar3,4, Emira Khelifa5, Arij Ben Chaaben6, Sabria Khouadja6, Fayza Ayari6, Ons Mihoub6, Ryad Tamouza7,8, Fethi Guémira6, Zouhaier Elhechmi5.   

Abstract

Bipolar disorder is a chronic, disabling disease that is characterized by the recurrence of thymic episodes. The role of the immune-inflammatory system in the etiopathogenesis of this affection arouses the interest of research. The aim of this work was to determine the plasma levels of the high sensitivity C reactive protein (hs-CRP) in patients with bipolar disorder in remission phase by comparing them to a control group.A case-control cross-sectional study was conducted from 56 subjects with bipolar disorder in clinical remission, and 56 volunteers and healthy control subjects.Mean plasma hs-CRP was significantly higher in patients with bipolar disorder than control subjects. In bipolar patients, a hs-CRP elevation was significantly associated with the disease severity item mean score.Through this study, bipolar disorder appears to be associated with a state of chronic inflammation. This should lead to randomized controlled trials evaluating the value of anti-inflammatory drugs in the management of bipolar disorder.

Entities:  

Keywords:  Bipolar disorder; C-reactive protein; Inflammation; Inflammatory marker

Year:  2020        PMID: 33094434     DOI: 10.1007/s11126-020-09854-y

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  18 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  Autoimmune diseases, bipolar disorder, and non-affective psychosis.

Authors:  William W Eaton; Marianne G Pedersen; Philip R Nielsen; Preben Bo Mortensen
Journal:  Bipolar Disord       Date:  2010-09       Impact factor: 6.744

3.  Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis.

Authors:  B S Fernandes; M Berk; C W Turck; J Steiner; C-A Gonçalves
Journal:  Mol Psychiatry       Date:  2013-12-17       Impact factor: 15.992

Review 4.  Revisiting inflammation in bipolar disorder.

Authors:  Gabriel R Fries; Consuelo Walss-Bass; Moises E Bauer; Antonio L Teixeira
Journal:  Pharmacol Biochem Behav       Date:  2018-12-24       Impact factor: 3.533

Review 5.  Inflammatory mediators of cognitive impairment in bipolar disorder.

Authors:  Isabelle E Bauer; Michaela C Pascoe; Bianca Wollenhaupt-Aguiar; Flavio Kapczinski; Jair C Soares
Journal:  J Psychiatr Res       Date:  2014-05-02       Impact factor: 4.791

6.  Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder.

Authors:  Faith Dickerson; Cassie Stallings; Andrea Origoni; Crystal Vaughan; Sunil Khushalani; Robert Yolken
Journal:  J Affect Disord       Date:  2013-05-17       Impact factor: 4.839

7.  Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder.

Authors:  Elisa Brietzke; Márcia Kauer-Sant'Anna; Antônio Lúcio Teixeira; Flávio Kapczinski
Journal:  Brain Behav Immun       Date:  2009-05-04       Impact factor: 7.217

Review 8.  A systematic review and meta-analysis of premature mortality in bipolar affective disorder.

Authors:  J F Hayes; J Miles; K Walters; M King; D P J Osborn
Journal:  Acta Psychiatr Scand       Date:  2015-03-03       Impact factor: 6.392

9.  Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity.

Authors:  Neil A Harrison; Lena Brydon; Cicely Walker; Marcus A Gray; Andrew Steptoe; Hugo D Critchley
Journal:  Biol Psychiatry       Date:  2009-05-07       Impact factor: 13.382

Review 10.  So depression is an inflammatory disease, but where does the inflammation come from?

Authors:  Michael Berk; Lana J Williams; Felice N Jacka; Adrienne O'Neil; Julie A Pasco; Steven Moylan; Nicholas B Allen; Amanda L Stuart; Amie C Hayley; Michelle L Byrne; Michael Maes
Journal:  BMC Med       Date:  2013-09-12       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.